IVD medical reports share repurchase, treasury holdings increase

IVD Medical Holding Limited announced a submission regarding changes in its issued and treasury shares as of November 17, 2025. The company repurchased 593,000 ordinary shares on the Exchange at a volume-weighted average price of HK$6.14 per share, with prices ranging from HK$5.97 to HK$6.25. This repurchase activity led to a 0.04% decrease in issued shares (excluding treasury shares), from 1,611,415,096 to 1,610,822,096.

Concurrently, the number of treasury shares held by the company increased by 593,000, bringing the total from 10,073,000 to 10,666,000. Despite these changes, the total number of issued shares remained at 1,621,488,096. The aggregate price paid for these repurchased shares totaled HK$3,638,960.

The repurchase was made under a mandate granted on June 30, 2025, which authorized the company to repurchase up to 162,148,809 shares. As of the reporting date, the company has repurchased 10,666,000 shares under this mandate, representing 0.66% of the issued shares (excluding treasury shares) at the time of the resolution. A moratorium period for new share issues or sales/transfers of treasury shares is in effect until December 17, 2025.